Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

Exclusion Criteria

• •Other current psychiatric disorder as the clinically predominant diagnosis.
• •Lifetime diagnosis of schizophrenia or any other psychosis, MDD with psychotic features, intellectual disability, autism spectrum disorders, bipolar disorder type 1, and cannabis use disorder
• •Previous 6 months diagnosis of Post-traumatic stress disorder, obsessive compulsive disorder, moderate to severe alcohol use disorder, and substance abuse disorder (except tobacco use disorder or mild alcohol use disorder)
• •Severe MDD
• •Use of oral psychoactive medications or beta adrenergic antagonists in the past 4 weeks, or depot neuroleptics within 12 weeks
• •Electroconvulsive therapy within 6 months, psychotherapy or transcranial magnetic stimulation within 3 months
• •Clinically significant abnormality or clinically significant unstable medical condition
• •Impaired liver function
• •Significant risk of suicide or homicide
• •Pregnancy/lactation
• •Sensitivity to CBD or excipients
• •Current cannabis use; past frequent cannabis use
• •Illegal drug use